Performance evaluation of in-house magnetized red cells prepared by Regional Blood Centre II Lopburi Province, Thai Red Cross Society for ABO serum grouping using the QWALYS® 3 EVO automated analyzer

Authors

  • Patcharakorn Kramkratok Regional Blood Centre II Lopburi Province, Thai red cross society
  • Sirikorn Phengthaworn Regional Blood Centre II Lopburi Province, Thai Red Cross Society
  • Piyawan Thammakorn Regional Blood Centre II Lopburi Province, Thai Red Cross Society

Keywords:

ABO serum grouping, Erythrocyte-magnetized technology, In-house magnetized cells, การตรวจหมู่โลหิต เอ บี โอ ในซีรัม, เครื่องคลอลิส อีโว, เทคโนโลยีการทำให้เม็ดเลือดแดงมีความเป็นแม่เหล็ก, การผลิตเม็ดเลือดแดงที่มีความเป็นแม่เหล็กขึ้นมาเอง, QWALYS 3 EVO

Abstract

Abstract:

Introduction:  ABO blood group testing using the QWALYS® 3 EVO analyzer employs erythrocyte-magnetized technology (EMT) with HEMALYS A1, B cells manufactured, imported from France. However, dependency on imported products poses risks, especially during crises, including the COVID-19 pandemic, which caused delivery delays and quality issues including hemolysis. Objective: This study aimed to evaluate the performance of ready-to-use in-house magnetized A1, B and O cells for ABO serum grouping. Materials and Methods: This prospective experimental study evaluated the performance of two formulations of in-house magnetized A1, B and O cells: standard formula (diluentlys 5 mL + magnelys reagent 75 µL + standard cells 80 µL each) and EDTA-supplemented formula (diluentlys 4 mL + magnelys reagent 75 µL + standard cells 80 µL each + EDTA 1.8 g/L, 1 mL). Performance was compared with HEMALYS A1, B using 1,123 known samples and 560 routine unknown samples. Cell stability was evaluated for 35 days. Testing was performed on the QWALYS® 3 EVO analyzer and confirmed with standard tube test (STT) for uninterpreted reactions. Results: Among 1,123 known samples, in-house magnetized cells with EDTA showed 98.04% accuracy (1,101 samples), comparable to HEMALYS A1, B cells at 98.13% (1,102 samples), with very high agreement (Kappa = 0.9462). Standard in-house magnetized cells without EDTA showed 90.29% accuracy (1,014 samples) with Kappa = 0.8412. Parallel testing with unknown samples showed 100% concordance. Both formulations demonstrated good stability for 35 days without contamination or hemolysis. Conclusion: In-house magnetized cells with EDTA demonstrated performance equivalent to imported products and can serve as a cost-effective alternative to reduce import dependency and enhance national blood service system security efficiently.

Downloads

Download data is not yet available.

References

Reid M, Shine I. The discovery and significance of the blood groups. Massachusetts: SBB Books; 2012.

International Society of Blood Transfusion. Red cell immunogenetics and blood group terminology [Internet]. Amsterdam: ISBT; [cited 2025 Apr 3]. Available from: https://www.isbtweb.org/isbt-working-parties/rcibgt.html.

Pechchantorn, S. Blood groups. Bangkok: The Thai Society of Hematology. Available from: https://tsh.or.th/Knowledge/Details/69 1 Jan, 2024.

E for L International Co. Standard operation procedure for QWALYS® 3 EVO analyzer. France: Diagast; 2014.

QWALYS® 3 EVO EM technology [Internet]. France: Diagast; [cited 2024 Jan 1]. Available from: https://www.diagast.com/en/automatons-reagents/automate-methods/QWALYS-3-evo-en/em-technology/

Bouix O, Ferrera V, Delamaire M, Redersdorff JC, Roubinet F. Erythrocyte-magnetized technology: an original and innovative method for blood group serology. Transfusion. 2008;48:1878-85.

Schoenfeld H, Bulling K, Von Heymann C, Neuner B, Kalus U, Kiesewetter H, et al. Evaluation of immunohematologic routine methods using the new Erythrocyte-magnetized technology on the QWALYS 2 system. Transfusion. 2009;49:1347-52.

Vashiraporn Y, Kasama E, Sathit T. Preparation of magnetized red cells for ABO serum grouping by Qwalys 3 blood grouping automation. J Hematol Transfus Med. 2020;30:119-27.

Roback JD, Combs MR, Grossman BJ, Harris T, Hillyer CD, eds. Technical manual. 16th ed. Bethesda, MD: AABB; 2008. p. 368-72.

Roback JD, Combs MR, Grossman BJ, Harris T, Hillyer CD, eds. Technical manual. 16th ed. Bethesda, MD: AABB; 2008. p. 899-900.

Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.

Banerjee C, Capozzoli M, McSweeney L, Sinha D. Beyond kappa: a review of interrater agreement measures. Can J Stat. 1999;27:3-23.

Reis KJ, Chachowski R, Cupido A, Davies D, Jakway J, Setcavage TM. Column agglutination technology: the antiglobulin test. Transfusion. 1993;33:639-43.

Ranjan V, Khillan K. Naturally occurring anti-M with high thermal amplitude complicating ABO blood grouping. Curr Med Res Pract. 2018;8:71-2.

Samarah F, Srour M. An unusual report of anti-N antibody presenting as ABO discrepancy in an old female patient in Palestine. Asian J Transfus Sci. 2019;13:140-1.

Ferdowsi S, Mohammadi S, Ahmadnezhad M, Herfat F, Rezvani A, Eshghi P, et al. Naturally occurring anti-P1 with high thermal amplitude complicating ABO blood grouping. Asian J Transfus Sci. 2024;18:135-7.

Sathima L, Kulvara A, Pasuporn P. AB para-Bombay phenotype with anti-H a case report. J Hematol Transfus Med. 2019;29:131-7.

National Blood Centre, Thai Red Cross Society. National blood service operation plan of Thailand 2022–2027. 1st ed. Bangkok: Udomsuksa; 2021. p. 26-40.

Downloads

Published

2025-07-01

Issue

Section

นิพนธ์ต้นฉบับ (Original article)